Moderna and Catalent in Deal to Package Covid Vaccine


Moderna  (MRNA) – Get Report and Catalent  (CTLT) – Get Report unveiled a joint effort to release Moderna’s coronavirus-vaccine candidate this quarter.

Drug-delivery specialist Catalent will provide vial-filling and -packaging services for drugmaker Moderna’s coronavirus vaccine candidate mRNA-1273, the companies said.

The agreement also involves Catalent, Somerset, N.J., providing additional staffing at Catalent’s biologics facility in Bloomington, Ind. 

The employees will support production of an initial 100 million doses of the drug to supply the U.S. market starting in the third quarter this year.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *